Solar manufacturing group seeks US trade probe of cell imports from South Korea

WASHINGTON: Three solar panel makers urged US officials to investigate cell imports from South Korea, saying firms, including Hanwha’s Qcells, were using them to evade tariffs on Chinese products, according to a petition seen by Reuters.

The petition was filed with the commerce department on June 18 on behalf of a manufacturing joint venture of Canadian Solar,  SEG and Heliene, which all operate solar panel factories in the US.

The group, calling itself American Manufacturers for Energy Resilience (AMER), is seeking an anti-circumvention probe, accusing Qcells of shifting cell production to South Korea from China to avoid US tariffs.

Cells are the building blocks of modules, or panels, that convert sunlight into electricity.

Under US trade law, tariffs can be extended to goods routed through third countries when processing there is minor.

An attorney for the group said it was seeking fairness.

“It is time that companies like Hanwha Qcells, that have been allowed to game both sides of US trade law for far too long, are held accountable,” attorney John Anwesen said.

“The AMER coalition is focused on leveling the playing field to allow fair competition across American solar manufacturers, and this circumvention inquiry request is a step towards that goal,” Anwesen said in a statement.

Qcells has two solar factories in the US state of Georgia and has a goal to manufacture all the key components that go into a silicon-based solar panel on US soil.

Qcells, which has invested billions into its US manufacturing operations, has been a driving force behind recent US trade petitions targeting solar imports from countries in Southeast Asia.

Some of those imports supplied factories owned by Canadian Solar, SEG and Heliene.

“Qcells has led the effort to reshore solar manufacturing in the US, and we have a decade-long record of supporting strong trade enforcement, not evading it,” Qcells spokeswoman Marta Stoepker said in an emailed statement.

“We’ve reviewed this filing and are confident the evidence will show its claims are without merit,” Stoepker said.